Engineering Multifunctional RNAi Nanomedicine To Concurrently Target Cancer Hallmarks for Combinatorial Therapy

Author:

Liu Yanlan12ORCID,Ji Xiaoyuan1,Tong Winnie W. L.1,Askhatova Diana1,Yang Tingyuan13,Cheng Hongwei4,Wang Yuzhuo4,Shi Jinjun1ORCID

Affiliation:

1. Center for Nanomedicine and Department of Anesthesiology; Brigham and Women's Hospital; Harvard Medical School; Boston MA 02115 USA

2. Molecular Science and Biomedicine Laboratory; State Key Laboratory of Chemo/Biosensing and Chemometrics; College of Chemistry and Chemical Engineering; Hunan University; Changsha 410082 P. R. China

3. State Key Laboratory of Biochemical Engineering; Institute of Process Engineering; Chinese Academy of Sciences; Beijing 100190 P. R. China

4. Department of Experimental Therapeutics; British Columbia Cancer Agency; Vancouver BC V5Z 1L3 Canada

Funder

National Institutes of Health

Prostate Cancer Foundation Young Investigator Award

Publisher

Wiley

Subject

General Chemistry,Catalysis

Cited by 180 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3